Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation

Neuropharmacology

Volumn 61, Issue 4, 2011, Pages 753-760

  Ostock, Corinne Y ^a   Dupre, Kristin B ^a   Eskow Jaunarajs, Karen L ^a   Walters, Hannah ^a   George, Jessica ^a   Krolewski, David ^b   Walker, Paul D ^b   Bishop, Christopher ^a  

^a BINGHAMTON UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Fos; l DOPA induced dyskinesia; Parkinson's disease; Primary motor cortex; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; LEVODOPA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN C FOS; SEROTONIN 1A RECEPTOR;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSKINESIA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; NONHUMAN; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; DYSKINESIA, DRUG-INDUCED; LEVODOPA; MALE; MOTOR CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR AGONISTS;

EID: 79959948761     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.05.021     Document Type: Article

References (44)

1. G.K. Aghajanian, and G.J. Marek Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells Neuropharmacology 36 4/5 1997 589 599 (Pubitemid 27272104)
2. I. Ahmed, S.K. Bose, N. Pavese, A. Ramlackhansingh, F. Turkheimer, G. Hotton, A. Hammers, and D.J. Brooks Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias Brain 134 2011 979 986
3. M. Andersson, A. Hilbertson, and M.A. Cenci Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease Neurobiol. Dis. 6 1999 461 474 (Pubitemid 30036616)
4. T. Antonelli, K. Fuxe, M.C. Tomasini, G.D. Bartoszyk, C.A. Seyfried, and S. Tangenelli Effects of Sarizotan on the corticostriatal glutamate pathways Synapse 58 2005 193 199 (Pubitemid 41443739)
5. R. Arai, N. Karasawa, M. Geffard, T. Nagatsu, and I. Nagatsu Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous l-DOPA in the rat, with reference to the involvement of aromatic l-amino acid decarboxylase Brain Res. 26 1994 295 299
6. W. Bara-Jimenez, F. Bibbiani, M.J. Morris, T. Dimitrova, A. Sherzai, and M.M. Mouradian Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease Mov. Disord. 20 2005 932 936 (Pubitemid 41419506)
7. F. Bibbiani, J.D. Oh, and T.N. Chase Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models Neurology 57 2001 1829 1834 (Pubitemid 33096691)
8. C. Bishop, J.L. Taylor, D.M. Kuhn, K.L. Eskow, J.L. Park, and P.D. Walker MDMA and fenfluramine reduce l-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation Eur. J. Neurosci. 23 2006 2669 2676 (Pubitemid 43801458)
9. C. Bishop, D.M. Krolewski, K.L. Eskow, C.J. Barnum, K.B. Dupre, and T. Deak Contribution of the striatum to the effects of 5-HT1A receptor stimulation in l-DOPA-treated hemiparkinsonian rats J. Neurosci. Res. 81 2009 1645 1658
10. D.J. Brooks, P. Piccini, N. Turjanski, and M. Samuel Neuroimaging of dyskinesia Ann. Neurol. 47 2000 S154 S158
11. X. Cao, T. Yasuda, S. Uthayathas, R.L. Watts, M.M. Mouradian, H. Mochizuki, and S.M. Papa Striatal overexpression of ΔFosB reproduces chronic levodopa-induced involuntary movements J. Neurosci. 30 2010 7335 7343
12. M. Carta, T. Carlsson, D. Kirik, and A. Bjorklund Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats Brain 130 2007 1819 1833 (Pubitemid 47343795)
13. M.A. Cenci, C.S. Lee, and A. Björklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706 (Pubitemid 28362576)
14. T.N. Chase, and J.D. Oh Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism Trends Neurosci. 23 2000 S86 S91
15. K.B. Dupre, K.L. Eskow, G. Negron, and C. Bishop The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat Brain Res. 1158 2007 135 143 (Pubitemid 47068412)
16. K.B. Dupre, K.L. Eskow, C.J. Barnum, and C. Bishop Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat Neuropharmacology 2008 1 8
17. K.B. Dupre, K.L. Eskow, A. Steiniger, A. Klioueva, G. Negron, and L. Lormand Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat Psychopharmacology 199 2008 99 108
18. K.B. Dupre, C.Y. Ostock, K.L. Eskow Jaunarajas, T. Button, L.M. Savage, W. Wolf, and C. Bishop Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats Exp. Neurol 229 2011 288 299
19. K.L. Eskow, V. Gupta, S. Alam, J.Y. Park, and C. Bishop The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy Pharmacol. Biochem. Behav. 87 2007 306 314 (Pubitemid 47101876)
20. K.L. Eskow, K.B. Dupre, C.J. Barnum, S.O. Dickinson, J.Y. Park, and C. Bishop The Role of the dorsal raphe nucleus in the development, expression, and treatment of l-dopa-induced dyskinesia in hemiparkinsonian rats Synapse 63 2009 610 620
21. G. Glynn, and S.O. Ahmad Three-dimensional electrophysiological topography of the rat corticostriatal system J. Comp. Physiol. A. Neuroethol. Sens. Neural Behav. Physiol. 188 2002 1432 1451
22. D.G. Herrera, and H.A. Robertson Activation of c-fos in the brain Prog. Neurobiol. 50 1996 83 107 (Pubitemid 26412595)
23. Huot, P., Johnston, T.H., Koprich, J.B., Winkelmolen, L., Fox, S.H., Brotchie, J.M., 2010. Regulation of cortical and striatal 5-HT(1A) receptors in the MPTP-lesioned macaque. Neurobiol. Aging. ahead of print.
24. M.M. Iravani, K. Tayarani-Binazir, W.B. Chu, M.J. Jackson, and P. Jenner In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OH-DPAT inhibits levodpoa-induced dyskinesia but only with increased motor disability J. Pharmacol. Exp. Ther. 319 2006 1225 1234
25. J. Jankovic Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations Mov. Disord. 20 2005 S11 S16
26. N. Jonkers, S. Sarre, G. Ebinger, and Y. Michotte MK801 suppresses the l-DOPA-induced increase of glutamate in striatum of hemi-parkinsonian rats Brain Res. 926 2002 149 155 (Pubitemid 34117600)
27. H.S. Lindgren, D.R. Andersson, S. Lagerkvist, H. Nissbrandt, and M.A. Cenci l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia J. Neurochem. 112 6 2010 1465 1476
28. A. Lopez, A. Munoz, M.J. Guerra, and J.L. Labanderia-Garcia Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum Neuroscience 103 2001 639 651 (Pubitemid 32239332)
29. M. Lundblad, M. Anderson, C. Winkler, D. Kirik, N. Wierup, and M.A. Cenci Pharmacological validation of behavioral measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur. J. Neurosci. 15 2002 120 132 (Pubitemid 35478015)
30. C. Marin, E. Aguilar, M.C. Rodriguez-Oroz, G.D. Bartoszyk, and J.A. Obeso Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats Psychopharmacology 204 2009 241 250
31. A.J. McGeorge, and R.L. Faull The organization of the projection from the cerebral cortex to the striatum in the rat Neuroscience 29 3 1989 503 537
32. L. Mignon, and W.A. Wolf 8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease Neuroreport 16 2005 699 703 (Pubitemid 40768641)
33. A. Mura, M. Mintz, and J. Feldon Behavioral and anatomical effects of long-term l-Dihydroxyphenylalanine (l-DOPA) administration in rats with unilateral lesions of the nigrostiatal system Exp. Neurol. 177 2002 252 264 (Pubitemid 35356838)
34. S. Navailles, A. Benazzouz, B. Bioulac, C. Gross, and P. De Deurwaerdre Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease Neurobiol. Dis. 38 2010 136 143
35. M.N. Pangalos, P.T. Francis, A.C. Foster, R.C.A. Pearson, D.N. Middlemiss, and D.M. Bowen NMDA receptors assessed by autoradiography with [3H]L-689,560 are present but not enriched on corticofugal-projecting pyramidal neurons Brain Res. 596 1992 223 230
36. G. Paxinos, and W. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press San Diego
37. M. Pompeiano, J.M. Palacios, and G. Mengod Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding J. Neurosci. 12 2 1992 440 453
38. O. Rascol, U. Sabatini, C. Brefel, N. Fabre, S. Rai, and J.M. Senard Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia Brain 121 1998 527 533 (Pubitemid 28116349)
39. I. Rektorova, S. Sedlackova, S. Telecka, A. Hlubocky, and I. Rektor Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation Int. J. Biomed. Imaging 2008 1 6
40. S. Robelet, C. Melon, B. Guillet, P. Salin, and L. Kerkerian-Le Goff Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease Eur. J. Neurosci. 20 5 2004 1255 1266 (Pubitemid 39233578)
41. M. Sheng, and M.E. Greenberg The regulation and function of c-fos and other immediate early genes in the nervous system Neuron 4 1990 477 485 (Pubitemid 20160837)
42. J.J. Soghomonian l-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus Eur. J. Neurosci. 23 2006 2395 2403
43. J.E. Westin, M. Andersson, M. Lundblad, and M.A. Cenci Persistent changes in striatal gene expression induced by long-term l-DOPA treatment in a rat model of Parkinson's disease Eur. J. Neurosci. 14 2001 1171 1176 (Pubitemid 35463761)
44. H. Yu, and T. Lewander Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat Eur. Neuropsychopharmacol. 7 1997 165 172 (Pubitemid 27278484)